Barclays »

Abivax SA F shares owned by Barclays

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $177M 1.3M 134.86
2025-09-30 $6.5M 76k 84.90
2025-06-30 $867k 113k 7.65
2025-03-31 $9.0k 1.5k 6.09
2024-12-31 $8.0k 1.1k 7.31

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
Octagon Capital Advisors
ADAR1 Capital Management
Barclays
Millennium Management
Westfield Capital Management Company
Vestal Point Capital
Adage Capital Partners GP

View all funds holding Abivax SA F